ClinVar Miner

Submissions for variant NM_000038.6(APC):c.3970C>G (p.Pro1324Ala)

dbSNP: rs587779792
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000115089 SCV000148998 uncertain significance not provided 2013-10-17 criteria provided, single submitter clinical testing This variant is denoted APC c.3970C>G at the cDNA level, p.Pro1324Ala (P1324A) at the protein level, and results in the change of a Proline to an Alanine (CCA>GCA). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. APC Pro1324Ala was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a semi-conservative substitution of a neutral non-polar amino acid for a neutral non-polar one, altering a position that is well conserved throughout evolution and is located in the in a region involved in ubiquitination leading to APC downregulation. In silico analyses predict this variant to have a benign effect on protein structure and function. Based on currently available information, it is unclear whether APC Pro1324Ala is pathogenic or benign. We consider it to be a variant of uncertain significance.
Invitae RCV003743563 SCV000647484 uncertain significance Familial adenomatous polyposis 1 2023-10-24 criteria provided, single submitter clinical testing This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 1324 of the APC protein (p.Pro1324Ala). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 127292). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt APC protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV001021555 SCV001183183 uncertain significance Hereditary cancer-predisposing syndrome 2022-07-22 criteria provided, single submitter clinical testing The p.P1324A variant (also known as c.3970C>G), located in coding exon 15 of the APC gene, results from a C to G substitution at nucleotide position 3970. The proline at codon 1324 is replaced by alanine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Color Diagnostics, LLC DBA Color Health RCV001021555 SCV001347423 uncertain significance Hereditary cancer-predisposing syndrome 2021-11-16 criteria provided, single submitter clinical testing This missense variant replaces proline with alanine at codon 1324 of the APC protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Sema4, Sema4 RCV001021555 SCV002536226 uncertain significance Hereditary cancer-predisposing syndrome 2021-08-12 criteria provided, single submitter curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.